US Stock MarketDetailed Quotes

TAK Takeda Pharmaceutical

Watchlist
  • 13.450
  • +0.340+2.59%
Trading May 14 09:43 ET
42.21BMarket Cap46.06P/E (TTM)

Takeda Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.69%716.34B
-5.14%278.59B
-61.28%146.45B
-9.99%198.91B
9.68%92.4B
-13.00%977.16B
-21.80%293.69B
8.84%378.23B
-5.22%220.99B
-49.51%84.24B
Net income from continuing operations
-54.52%144.2B
-109.62%-2.99B
-11.24%105.76B
-177.71%-47.97B
-14.87%89.41B
37.74%317.04B
373.71%31.14B
106.07%119.15B
34.21%61.73B
-23.75%105.02B
Operating gains losses
-550.25%-8.25B
-3,827.22%-7.07B
-63.84%413M
-419.36%-2.19B
224.46%597M
-77.63%1.83B
-104.77%-180M
-18.66%1.14B
-76.54%687M
113.95%184M
Depreciation and amortization
9.57%728B
15.70%186.74B
5.76%187.06B
8.86%182.7B
8.35%171.5B
13.93%664.4B
6.00%161.41B
20.10%176.88B
19.32%167.83B
10.73%158.28B
Deferred tax
-257.46%-91.41B
-365.38%-44.53B
-270.92%-44.5B
-1,804.26%-48.01B
-9.56%45.63B
-19.82%58.05B
139.32%16.78B
-183.46%-12B
-81.77%2.82B
-40.82%50.45B
Other non cash items
789.71%160.2B
208.01%80.88B
0.98%71.91B
-38.99%41.93B
26.62%-34.52B
-90.23%18.01B
-188.54%-74.89B
19.57%71.21B
36.91%68.72B
-369.56%-47.04B
Change In working capital
-913.31%-256B
-58.59%59.38B
-423.60%-166.02B
105.05%1.59B
19.91%-150.95B
-125.62%-25.26B
-19.75%143.39B
-28.36%51.3B
-441.81%-31.49B
-17.13%-188.47B
-Change in receivables
-79.90%15.1B
8.24%73.9B
11.88%14.29B
43.44%17.29B
-402.91%-90.37B
-40.98%75.13B
51.54%68.27B
-90.71%12.77B
190.27%12.06B
57.05%-17.97B
-Change in inventory
-46.22%-115.74B
128.38%12.75B
-173.82%-50.55B
-640.98%-49.35B
-213.54%-28.59B
-71.52%-79.16B
-552.83%-44.92B
-29.08%-18.46B
-68.35%-6.66B
56.60%-9.12B
-Change in payables and accrued expense
88.33%-9.9B
-150.66%-30.48B
1,011.24%70.27B
62.57%-15.02B
64.32%-34.66B
-167.76%-84.8B
-52.61%60.17B
-206.42%-7.71B
-353.85%-40.14B
-290.77%-97.12B
-Change in other current liabilities
-158.63%-18.57B
-121.61%-8.55B
-210.03%-44.19B
327.89%8.92B
157.20%25.25B
163.84%31.67B
2,453.23%39.58B
176.97%40.16B
-143.47%-3.92B
-452.94%-44.15B
-Change in other working capital
-497.82%-126.9B
-42.01%11.77B
-734.91%-155.83B
454.57%39.75B
-12.32%-22.58B
154.91%31.9B
69.00%20.29B
472.67%24.54B
320.35%7.17B
69.17%-20.11B
Cash from discontinued investing activities
Operating cash flow
-26.69%716.34B
-5.14%278.59B
-61.28%146.45B
-9.99%198.91B
9.69%92.4B
-13.00%977.16B
-21.80%293.69B
8.84%378.23B
-5.22%220.99B
-49.51%84.24B
Investing cash flow
Cash flow from continuing investing activities
23.59%-463.86B
85.98%-61.49B
-61.20%-75.27B
-122.66%-60.58B
-181.41%-266.53B
-206.42%-607.1B
-1,610.32%-438.49B
32.47%-46.69B
17.31%-27.21B
-34.45%-94.71B
Net PPE purchase and sale
-19.41%-166.81B
-27.65%-44.53B
-39.82%-46.81B
-0.98%-29.52B
-9.16%-45.95B
-15.03%-139.7B
-2.08%-34.89B
-23.78%-33.48B
4.00%-29.24B
-41.44%-42.09B
Net intangibles purchase and sale
38.08%-305.31B
95.15%-19.79B
-75.09%-30.04B
-184.64%-32.2B
-296.94%-223.28B
-685.27%-493.03B
-2,413.61%-408.31B
19.66%-17.16B
11.13%-11.31B
-351.67%-56.25B
Net business purchase and sale
150.80%19.96B
146.22%19.59B
--0
---7M
--372M
137.06%7.96B
-69.46%7.96B
--0
--0
--0
Net investment purchase and sale
-364.77%-32.05B
-844.17%-28.41B
-242.39%-2B
-114.36%-1.5B
-104.04%-131M
41.06%12.1B
-2,716.52%-3.01B
-29.20%1.41B
13.13%10.46B
217.23%3.25B
Net other investing changes
-31.19%-4B
-38.37%-3.92B
-83.85%63M
65.36%-133M
93.78%-14M
58.35%-3.05B
-7.11%-2.83B
111.50%390M
48.80%-384M
58.41%-225M
Cash from discontinued investing activities
Investing cash flow
23.59%-463.86B
85.98%-61.48B
-61.21%-75.27B
-122.67%-60.58B
-181.41%-266.53B
-206.42%-607.1B
-1,610.32%-438.49B
32.47%-46.69B
17.32%-27.21B
-34.45%-94.71B
Financing cash flow
Cash flow from continuing financing activities
50.02%-354.42B
-782.03%-58.22B
77.52%-97.76B
-171.14%-140.65B
73.22%-57.78B
33.74%-709.15B
97.29%-6.6B
-158.81%-434.96B
79.03%-51.88B
47.52%-215.72B
Net issuance payments of debt
100.53%1.51B
-149.19%-14.28B
127.61%73.49B
-1,358.81%-157.07B
367.62%99.37B
52.53%-285.07B
115.70%29.02B
-678.82%-266.2B
94.83%-10.77B
85.34%-37.13B
Net common stock issuance
91.36%-2.33B
--0
--0
--0
91.36%-2.33B
65.27%-26.93B
--0
--0
--0
-959.36%-26.93B
Cash dividends paid
-2.78%-287.19B
12.41%-9.13B
-7.18%-138.25B
18.58%-9.07B
-1.45%-130.75B
1.50%-279.42B
2.09%-10.42B
1.87%-128.99B
-16.70%-11.13B
2.39%-128.87B
Net other financing activities
470.06%33.96B
-308.68%-13.13B
31.98%-4.03B
213,084.62%55.38B
-26,506.25%-4.26B
-2,283.64%-9.18B
-17,750.00%-3.21B
-1,572.88%-5.92B
---26M
---16M
Cash from discontinued financing activities
Financing cash flow
50.02%-354.42B
-782.17%-58.22B
77.52%-97.76B
-171.14%-140.66B
73.22%-57.78B
33.74%-709.15B
97.29%-6.6B
-158.81%-434.96B
79.03%-51.88B
47.52%-215.72B
Net cash flow
Beginning cash position
-37.21%533.53B
-57.91%288.36B
-60.15%318.05B
-51.02%316.38B
-37.21%533.53B
-12.06%849.7B
-5.41%685.14B
31.30%798.14B
-1.36%645.99B
-12.06%849.7B
Current changes in cash
69.94%-101.93B
204.94%158.88B
74.30%-26.58B
-101.64%-2.33B
-2.53%-231.91B
-133.40%-339.09B
-242.63%-151.4B
-193.75%-103.42B
401.19%141.91B
28.11%-226.19B
Effect of exchange rate changes
14.28%26.2B
5,081.13%10.56B
67.48%-3.12B
-60.92%4B
-34.36%14.76B
-20.27%22.93B
-101.10%-212M
-255.83%-9.58B
13,021.79%10.24B
576.44%22.49B
End cash Position
-14.19%457.8B
-14.19%457.8B
-57.91%288.36B
-60.15%318.05B
-51.02%316.38B
-37.21%533.53B
-37.21%533.53B
-5.41%685.14B
31.30%798.14B
-1.36%645.99B
Free cash flow
-31.40%235.61B
242.47%214.26B
-78.84%69.33B
-28.56%128.86B
-1,151.06%-176.84B
-63.35%343.47B
-146.45%-150.39B
9.54%327.61B
-4.89%180.38B
-111.35%-14.14B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.69%716.34B-5.14%278.59B-61.28%146.45B-9.99%198.91B9.68%92.4B-13.00%977.16B-21.80%293.69B8.84%378.23B-5.22%220.99B-49.51%84.24B
Net income from continuing operations -54.52%144.2B-109.62%-2.99B-11.24%105.76B-177.71%-47.97B-14.87%89.41B37.74%317.04B373.71%31.14B106.07%119.15B34.21%61.73B-23.75%105.02B
Operating gains losses -550.25%-8.25B-3,827.22%-7.07B-63.84%413M-419.36%-2.19B224.46%597M-77.63%1.83B-104.77%-180M-18.66%1.14B-76.54%687M113.95%184M
Depreciation and amortization 9.57%728B15.70%186.74B5.76%187.06B8.86%182.7B8.35%171.5B13.93%664.4B6.00%161.41B20.10%176.88B19.32%167.83B10.73%158.28B
Deferred tax -257.46%-91.41B-365.38%-44.53B-270.92%-44.5B-1,804.26%-48.01B-9.56%45.63B-19.82%58.05B139.32%16.78B-183.46%-12B-81.77%2.82B-40.82%50.45B
Other non cash items 789.71%160.2B208.01%80.88B0.98%71.91B-38.99%41.93B26.62%-34.52B-90.23%18.01B-188.54%-74.89B19.57%71.21B36.91%68.72B-369.56%-47.04B
Change In working capital -913.31%-256B-58.59%59.38B-423.60%-166.02B105.05%1.59B19.91%-150.95B-125.62%-25.26B-19.75%143.39B-28.36%51.3B-441.81%-31.49B-17.13%-188.47B
-Change in receivables -79.90%15.1B8.24%73.9B11.88%14.29B43.44%17.29B-402.91%-90.37B-40.98%75.13B51.54%68.27B-90.71%12.77B190.27%12.06B57.05%-17.97B
-Change in inventory -46.22%-115.74B128.38%12.75B-173.82%-50.55B-640.98%-49.35B-213.54%-28.59B-71.52%-79.16B-552.83%-44.92B-29.08%-18.46B-68.35%-6.66B56.60%-9.12B
-Change in payables and accrued expense 88.33%-9.9B-150.66%-30.48B1,011.24%70.27B62.57%-15.02B64.32%-34.66B-167.76%-84.8B-52.61%60.17B-206.42%-7.71B-353.85%-40.14B-290.77%-97.12B
-Change in other current liabilities -158.63%-18.57B-121.61%-8.55B-210.03%-44.19B327.89%8.92B157.20%25.25B163.84%31.67B2,453.23%39.58B176.97%40.16B-143.47%-3.92B-452.94%-44.15B
-Change in other working capital -497.82%-126.9B-42.01%11.77B-734.91%-155.83B454.57%39.75B-12.32%-22.58B154.91%31.9B69.00%20.29B472.67%24.54B320.35%7.17B69.17%-20.11B
Cash from discontinued investing activities
Operating cash flow -26.69%716.34B-5.14%278.59B-61.28%146.45B-9.99%198.91B9.69%92.4B-13.00%977.16B-21.80%293.69B8.84%378.23B-5.22%220.99B-49.51%84.24B
Investing cash flow
Cash flow from continuing investing activities 23.59%-463.86B85.98%-61.49B-61.20%-75.27B-122.66%-60.58B-181.41%-266.53B-206.42%-607.1B-1,610.32%-438.49B32.47%-46.69B17.31%-27.21B-34.45%-94.71B
Net PPE purchase and sale -19.41%-166.81B-27.65%-44.53B-39.82%-46.81B-0.98%-29.52B-9.16%-45.95B-15.03%-139.7B-2.08%-34.89B-23.78%-33.48B4.00%-29.24B-41.44%-42.09B
Net intangibles purchase and sale 38.08%-305.31B95.15%-19.79B-75.09%-30.04B-184.64%-32.2B-296.94%-223.28B-685.27%-493.03B-2,413.61%-408.31B19.66%-17.16B11.13%-11.31B-351.67%-56.25B
Net business purchase and sale 150.80%19.96B146.22%19.59B--0---7M--372M137.06%7.96B-69.46%7.96B--0--0--0
Net investment purchase and sale -364.77%-32.05B-844.17%-28.41B-242.39%-2B-114.36%-1.5B-104.04%-131M41.06%12.1B-2,716.52%-3.01B-29.20%1.41B13.13%10.46B217.23%3.25B
Net other investing changes -31.19%-4B-38.37%-3.92B-83.85%63M65.36%-133M93.78%-14M58.35%-3.05B-7.11%-2.83B111.50%390M48.80%-384M58.41%-225M
Cash from discontinued investing activities
Investing cash flow 23.59%-463.86B85.98%-61.48B-61.21%-75.27B-122.67%-60.58B-181.41%-266.53B-206.42%-607.1B-1,610.32%-438.49B32.47%-46.69B17.32%-27.21B-34.45%-94.71B
Financing cash flow
Cash flow from continuing financing activities 50.02%-354.42B-782.03%-58.22B77.52%-97.76B-171.14%-140.65B73.22%-57.78B33.74%-709.15B97.29%-6.6B-158.81%-434.96B79.03%-51.88B47.52%-215.72B
Net issuance payments of debt 100.53%1.51B-149.19%-14.28B127.61%73.49B-1,358.81%-157.07B367.62%99.37B52.53%-285.07B115.70%29.02B-678.82%-266.2B94.83%-10.77B85.34%-37.13B
Net common stock issuance 91.36%-2.33B--0--0--091.36%-2.33B65.27%-26.93B--0--0--0-959.36%-26.93B
Cash dividends paid -2.78%-287.19B12.41%-9.13B-7.18%-138.25B18.58%-9.07B-1.45%-130.75B1.50%-279.42B2.09%-10.42B1.87%-128.99B-16.70%-11.13B2.39%-128.87B
Net other financing activities 470.06%33.96B-308.68%-13.13B31.98%-4.03B213,084.62%55.38B-26,506.25%-4.26B-2,283.64%-9.18B-17,750.00%-3.21B-1,572.88%-5.92B---26M---16M
Cash from discontinued financing activities
Financing cash flow 50.02%-354.42B-782.17%-58.22B77.52%-97.76B-171.14%-140.66B73.22%-57.78B33.74%-709.15B97.29%-6.6B-158.81%-434.96B79.03%-51.88B47.52%-215.72B
Net cash flow
Beginning cash position -37.21%533.53B-57.91%288.36B-60.15%318.05B-51.02%316.38B-37.21%533.53B-12.06%849.7B-5.41%685.14B31.30%798.14B-1.36%645.99B-12.06%849.7B
Current changes in cash 69.94%-101.93B204.94%158.88B74.30%-26.58B-101.64%-2.33B-2.53%-231.91B-133.40%-339.09B-242.63%-151.4B-193.75%-103.42B401.19%141.91B28.11%-226.19B
Effect of exchange rate changes 14.28%26.2B5,081.13%10.56B67.48%-3.12B-60.92%4B-34.36%14.76B-20.27%22.93B-101.10%-212M-255.83%-9.58B13,021.79%10.24B576.44%22.49B
End cash Position -14.19%457.8B-14.19%457.8B-57.91%288.36B-60.15%318.05B-51.02%316.38B-37.21%533.53B-37.21%533.53B-5.41%685.14B31.30%798.14B-1.36%645.99B
Free cash flow -31.40%235.61B242.47%214.26B-78.84%69.33B-28.56%128.86B-1,151.06%-176.84B-63.35%343.47B-146.45%-150.39B9.54%327.61B-4.89%180.38B-111.35%-14.14B
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg